Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile is used as a reagent in the study of pharmaceutical combination therapies for the treatment or prevention of arthritis.